06 August 2021>: Lab/In Vitro Research
Human Umbilical Cord Mesenchymal Stem Cell Therapy Mitigates Interstitial Cystitis by Inhibiting Mast Cells
Yuancheng Xu ABDEF* , Fei Yang BC , Juncong Xie BC , Wenbiao Li BC , Bolong Liu BD , Jialiang Chen BC , Honglu Ding BC , Jiarong Cai EFDOI: 10.12659/MSM.930001
Med Sci Monit 2021; 27:e930001
Figure 1 5-Ethynyl-2-deoxyuridine (EdU) labeling of UC-MSCs in vitro and tracking EdU-labeled human umbilical cord-derived mesenchymal stem cells (UC-MSCs) in vivo. UC-MSCs labeled by EdU and stained with Apollo 567 (A, red fluorescence) and Hoechst 33342 (B, blue fluorescence). EdU-labeled UC-MSCs stained with Apollo 567 in harvested rat bladders (E, red fluorescence), Hoechst 33342 (F, blue fluorescence). The boxed areas in the ×40 magnified images in (C) and (G) were amplified ×200 in the corresponding (D) and (H), respectively. White arrows point to nuclei that are presented in the graphs.